Olympic champion Lin Yu-ting has been authorised to take part in women’s boxing after World Boxing confirmed she met the governing body’s new eligibility criteria. The 30-year-old Taiwanese pugilist, who secured the women’s featherweight title for Chinese Taipei at the 2024 Paris Olympics, had become caught up in a high-profile eligibility dispute alongside Algeria’s Imane Khelif. Both boxers were formerly banned from the 2023 World Championships by the International Boxing Association, which cited failure to meet female competition requirements. World Boxing, which assumed oversight of the sport at Olympic level after the IOC’s removal of the IBA, implemented compulsory sex screening in August 2025. Lin’s approval comes after a completed appeal process and health assessment by World Boxing’s independent experts.
The eligibility scandal that rocked Olympic boxing
Lin Yu-ting’s clearance marks a pivotal moment in one of Olympic sport’s most contentious eligibility rows. The dispute broke out when the IBA disqualified both Lin and Khelif from the 2023 World Championships, stating they had failed to meet the requirements for participation in women’s events. In spite of this rejection, Lin subsequently win Olympic gold in Paris shortly afterwards, competing under IOC supervision after the regulatory authority revoked the IBA of its status due to significant integrity and governance issues. The affair revealed significant fractures within the boxing establishment and raised intricate questions about eligibility testing and fairness in women’s sport.
The controversy amplified the oversight surrounding qualification standards in women’s boxing at the elite echelons of competition. Lin’s withdrawal from many tournaments subsequent to World Boxing’s implementation of compulsory gender testing in August 2025 reflected the uncertainty concerning her status. The appeals procedure, whilst thorough and eventually cleared the athlete, emphasised the psychological and career impact of prolonged eligibility questions. World Boxing’s decision to implement impartial clinical assessment procedures signified an effort to create clearer, more transparent standards for the activity moving forward.
- IBA disqualified Lin and Khelif from 2023 World Championships
- IOC suspended IBA citing governance failures and integrity concerns
- Lin secured Olympic gold despite eligibility row in Paris
- World Boxing introduced compulsory sex testing in August 2025
World Boxing’s updated testing protocol explained
World Boxing’s mandatory sex testing policy, introduced in August 2025, constitutes a fundamental shift in how the sport approaches eligibility assessment. The updated system focuses on a specific genetic test intended to determine biological sex through scientific evaluation, replacing the former approach that had generated widespread controversy. This approach aims to deliver objective criteria that can be measured that World Boxing argues will protect both competitive fairness and athlete safety. The policy covers all competitors in women’s divisions and features a structured appeal process, allowing athletes to dispute initial findings with accompanying medical documentation. This structure is intended to create consistency and openness across international boxing competitions.
The implementation of mandatory testing has demonstrated importance for athletes like Lin Yu-ting, who faced extended uncertainty whilst the new system was established. World Boxing’s decision to include an autonomous medical evaluation mechanism indicates understanding of the complications involved in eligibility determinations. The appeals mechanism enables competitors to provide detailed medical records for evaluation by World Boxing’s Medical Committee, making certain that personal situations receive proper consideration. This equitable method endeavours to integrate scientific rigour with procedural fairness, accepting that biological sex cannot always be clearly defined. The body underlines that the policy’s primary objective is maintaining competitive fairness whilst defending athlete welfare and dignity throughout the verification process.
How the SRY genetic test operates
The SRY gene test works by identifying the existence of a specific gene that World Boxing recognises as an indicator of male biological sex. The test analyses genetic material to establish whether the Y chromosome is detected, which typically characterises male development. According to World Boxing, this genetic marker offers an objective biological measurement that can inform eligibility decisions. The test reflects a move towards scientific procedures in determining sex determination, departing from previous approaches that were based on different criteria. Results are reviewed by independent medical professionals who assess the findings within broader clinical context.
Athletes who test positive for the SRY gene are not automatically disqualified; instead, they proceed through an appeal process allowing them to submit additional medical evidence. World Boxing’s Medical Committee reviews all provided documentation comprehensively before making final eligibility decisions. This appeals mechanism acknowledges that genetic testing alone may not provide the complete biological picture, particularly for athletes with conditions impacting sex development. The assessment process considers clinical history, hormone levels, and other pertinent clinical factors alongside genetic results. This multi-faceted approach aims to guarantee that decisions are scientifically sound and individually appropriate rather than determined solely on single test results.
- Identifies Y chromosome presence indicating male biological sex
- Positive results activate standalone clinical assessment appeals procedure
- Clinical Panel examines genetic and clinical data comprehensively
The appeals process and medical documentation
Following an preliminary assessment in 2025, the Chinese Taipei Boxing Association initiated a formal appeal on Lin’s behalf, providing detailed medical evidence to World Boxing for impartial examination. The appeal mechanism is a essential protection within World Boxing’s eligibility framework, allowing athletes to contest initial test results by providing supporting clinical evidence. This process acknowledges that biological sex determination is multifaceted and that genetic markers alone cannot tell the full picture of an person’s clinical background and biological makeup. The CTBA’s decision to pursue the challenge demonstrated confidence in Lin’s case and dedication to exonerating her through official procedures.
The provision of medical documents represented a crucial turning point in the resolution of Lin’s eligibility status. World Boxing’s medical specialists performed a thorough evaluation of the evidence provided, taking into account not only genetic test results but also wider medical considerations such as hormonal measurements, clinical background, and other relevant biological factors. This thorough methodology guaranteed that the decision was based on full clinical evaluation rather than isolated test results. The stringent examination procedure demonstrated World Boxing’s commitment to making decisions that are both scientifically sound and personally suitable, whilst preserving the integrity of women’s competition.
What the medical board concluded
The World Boxing Medical Committee established that Lin had been female since birth and fulfilled all criteria for competing in the female category, with no unfair advantage. This determination came after careful evaluation of the clinical evidence and constituted a definitive resolution to the eligibility issue that had dominated her career since the 2023 World Championships. The committee’s determination confirmed Lin’s ability to compete at the highest levels of women’s boxing, clearing the path for her comeback in international competition.
What lies ahead for Lin and women’s boxing
Lin’s clearance marks a pivotal moment not only for her career but for women’s boxing in general. The 30-year-old can now return to competition in competitions sanctioned by World Boxing after sitting out many events since the compulsory sex testing requirement was established in August 2025. Her return provides a possibility of regaining her status as a two-time world champion and expand upon her gold medal win from Paris. The resolution also offers resolution for the CTBA, which has steadfastly supported Lin throughout the disputed eligibility proceedings and welcomed the confirmation of her status.
The case has wider significance for how international sports bodies approach eligibility policies and competitor wellbeing. World Boxing’s decision to implement a thorough appeals mechanism with impartial medical assessment sets a precedent for balancing sporting fairness with personal justice. As Lin prepares to return to the ring, her return to competition will be carefully monitored by the professional boxing world and further afield, possibly shaping how other sports federations create and improve their own eligibility frameworks. The pathway forward underscores the significance of comprehensive, open procedures that respect both the science of sex determination and the personal respect of athletes.
| Upcoming Event | Details |
|---|---|
| World Boxing Championships | Lin eligible to compete in women’s featherweight category |
| 2028 Olympic Games | Opportunity to defend Olympic title from Paris 2024 |
| Asian Championships | Potential to add to her two previous Asian titles |
- Lin can now compete in all World Boxing-sanctioned global tournaments without restrictions.
- The appeals procedure reflects World Boxing’s pledge of impartial, evidence-driven qualification assessments.
- Her return strengthens faith in women’s boxing oversight under this new regulatory structure.